FIIs increase stake in 264 smallcap stocks, 3 of them turn multibagger in 2025. Do you own any?
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Foreign institutional investors (FIIs), who have been hunting for greener pastures in the broader market, found at least 3 of their Q1 picks delivering explosive multibagger returns of up to 165% in 2025 alone, leaving retail investors scrambling to catch up.An analysis of shareholding pattern data from the June quarter reveals that FIIs raised stakes in at least 264 smallcap stocks . The standout winner has been Force Motors , which makes engines for the likes of Mercedes, BMW and Rolls Royce Daimler. The stock is up 165% year-to-date and FIIs have increased their holding from 8.36% to 9.77%.The foreign money managers' Midas touch extends beyond just Force Motors. Camlin Fine Sciences delivered a hefty 125% return where FIIs have nearly doubled their stake from 1.47% to 2.88% in just 3 months. Gabriel India rounds out the multibagger trio with a 107% gain, as foreign investors boosted their position from 5.23% to 5.97%.But the success story doesn't end there. A remarkable 17 stocks from the FII-backed list have delivered returns of at least 50% in 2025, creating a winners' circle that includes Lumax Auto Technologies (77%), Authum Investment & Infrastructure (69%), and RBL Bank (65%).The automotive sector emerges as a clear FII favorite, with multiple auto component companies featuring prominently in the high-returns list. Lumax Industries gained 66% alongside its sister company Lumax Auto Technologies, while Federal-Mogul Goetze India surged 55% despite FIIs adding just 14 basis points to their holding.Apollo Micro Systems saw the largest stake increase, with FII holding jumping from 0.93% to 7.16%, a massive 623 basis point surge that coincided with a solid 56% stock gain.Defense and infrastructure stocks have also caught FII attention. PSU defence stock GRSE delivered 60% returns as FII stakes rose to 5.33% from 3.85%, while Bharat Dynamics gained 53.18% with foreign holdings increasing to 3.77%.The financial services sector represents another FII hunting ground. RBL Bank's 65% surge came alongside a significant 313 bps increase in FII holding to 17.56%. Similarly, Cholamandalam Financial Holdings rewarded foreign investors with 52% returns as they raised stakes to 18.32%.Even modest FII increases have translated into meaningful returns. Navin Fluorine International gained 53% despite FII holdings rising by just 139 bps, while specialty chemicals player Shankara Building Products delivered 53% returns as FII stakes nearly doubled from 5.69% to 10.55%.Healthcare stocks haven't escaped FII radar either. Narayana Hrudayalaya provided 51% returns with FII holding climbing to 10.46%, demonstrating the breadth of foreign investor interest across sectors.The foreign investors' smallcap strategy appears particularly focused on auto ancillaries, financial services, specialty chemicals, defence, and healthcare, sectors that have been riding India's economic momentum and structural growth themes.However, not all FII picks have delivered immediate gratification. Some high-profile names in the list have struggled, with stocks like Advanced Enzyme Technologies declining 4.36% despite FIIs dramatically increasing their stake by 1155 bps to 23.45%. This underscores that even sophisticated foreign money managers aren't immune to market volatility.Domestic brokerage firm Emkay Global has recently revamped its model portfolio to include small and midcap stocks and reduce largecap holdings."Our model portfolio is primarily large-cap focused (Rs500bn+ market cap) with a dedicated 40% allocation to a fixed basket of 5 SMID-cap stocks as a strategic carve-out within the model portfolio is run on a top-down basis from within our Emkay universe," it said. Emkay's 5 small and midcap ideas include Bikaji Foods, Motilal Oswal. Shriram Pistons, Metropolis Healthcare and Voltas.However, analysts point out that midcap stocks have outperformed smallcaps over the long term due to better risk-adjusted returns, stronger business fundamentals, and higher survivability."While smallcaps offer higher short-term growth potential, they are more volatile and prone to failure. Midcaps, being more mature and financially stable, attract greater institutional interest and provide more consistent performance, making them a more reliable investment over extended periods," Equirus Wealth said.After a meaningful rally from April lows, valuations are no longer cheap."Largecaps are above long-term averages, and mid-/small-caps are trading at a premium. Still, headline P/Es mask the deeper story — midcaps continue to deliver stronger earnings growth and justify selective premium valuations. We now enter a phase where markets won't reward broad exposure. The easy beta-driven gains may be behind us. From here, business quality, earnings consistency, and management execution will define outcomes," it said.(Data: Ritesh Presswala)(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
22 minutes ago
- Mint
Indian shares inch lower as Kotak earnings drag financials, trade deal delay weighs
By Bharath Rajeswaran and Vivek Kumar M (Reuters) -Indian shares inched lower on Monday as weak results from Kotak Mahindra Bank weighed on sentiment, while uncertainty over trade talks with the U.S. added to overall caution. The Nifty 50 fell 0.16% to 24,798.9 points and the BSE Sensex lost 0.2% to 81,325.4 as of 10:03 a.m. IST. The broader small-caps and mid-caps lost 0.3% and 0.2%, respectively. Negotiations between India and the United States remained deadlocked over tariff cuts on agriculture and dairy products, dimming hopes of an interim deal ahead of U.S. President Donald Trump's August 1 deadline. This is in contrast to a framework trade agreement struck between the U.S. and European Union over the weekend, easing fears of a bigger trade war between the two allies, which account for almost a third of global trade. High-weightage financials and private banks lost 0.2% and 1%, respectively, dragged by a 7% fall in Kotak Mahindra Bank after it posted a drop in quarterly profit. The IT index lost 0.5%, with Tata Consultancy Services shedding 1.6% after it announced plans to reduce its workforce by 2% in fiscal year 2026. The Nifty 50 and 30-stock Sensex have logged four consecutive weekly losses due to weak earnings, foreign outflows and uncertainty over the U.S.-India trade deal. "A dull earnings season and the lingering delay in the India-U.S. trade deal have clearly cast a shadow on market sentiment. With valuations still stretched across the board, investors are understandably treading with heightened caution," said G Chokkalingam, founder and head of research at Equinomics Research. Among individual stocks, Mphasis gained 2.4% on posting quarterly results in-line with estimates and on strong deal bookings, which has boosted the IT company's revenue growth outlook. SBI Cards and Payment Services lost 3.7% after missing profit estimates in the June quarter. (Reporting by Vivek Kumar M and Bharath Rajeswaran; Editing by Eileen Soreng and Mrigank Dhaniwala)
Economic Times
22 minutes ago
- Economic Times
Market in consolidation mode; triggers needed, says Sunil Subramaniam
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment," says Sunil Subramaniam , Market like you said, the question is—why were they under pressure in the first place? I'd call it the Trump effect. Mr. Trump has been talking a lot about imposing heavy pharma tariffs. He hasn't actually done anything yet, but every time he makes such statements, it creates nervousness—whether he's targeting CDMO players or generics, and how he plans to go about it. That uncertainty has impacted the pharma sector, putting it under when individual companies are reporting good numbers, the market has no choice but to buy into them—because at least those companies are indicating a positive outlook. Plus, some of them may not even be impacted by tariffs, creating a window of opportunity. Also, the pharma space includes domestic-oriented businesses like hospitals and diagnostics, which are unaffected by U.S. tariff issues. So overall, pharma remains a defensive reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped we need to understand the market's movement over the last three months. Post-March, FIIs were actually buyers in April and May, and even in June, though to a lesser extent. Meanwhile, if you look at the end of March, mutual fund DIIs—especially domestic mutual funds—had built up cash positions to around 7.25% of their April and May, both mutual funds and FIIs were buying, which supported the market. But starting this month, mutual fund cash levels are back down to around 5%, which is close to their lower limit. That means DIIs don't have as much cash left to deploy, apart from the fresh SIP looking at last earnings season and market levels, domestic funds have largely deployed their cash. FIIs, on the other hand, had expected some action around the BTA by July 9, which then got pushed to August 1. But now, even that deadline seems unlikely to be met. The Indian trade delegation has returned from the U.S. without a deal. Sticking points remain—like agriculture—and they won't be easy to the question now is whether Trump will extend the 10% tariff pause beyond August 1 or slap a 26% tariff on India and then negotiate, like he did with Japan—imposing higher tariffs first and then signing a deal at 19%. That kind of uncertainty around the India-U.S. BTA is keeping FIIs factor is China. While China and the U.S. haven't signed a full BTA either, they seem to have reached some understanding. Meanwhile, China's markets have been beaten down so much that the one-year forward P/E is around 11—compared to India's 22. And China's economy is about 4.5 times larger than India's. Even at 4% growth, those are big numbers. So FIIs are starting to see more value in China, pulling some attention away from as for your question on the next trigger—clearly, a breakthrough on the BTA front, like an interim deal or assurance that tariffs will be capped below 20%, could bring FIIs back. On the domestic side, it's the ongoing earnings season. Results have been mixed. The IT sector, for instance, didn't post terrible earnings, but weak guidance is weighing heavily, especially in the absence of FII DIIs have already used most of their cash, their incremental buying will depend on the inflow from SIPs and earnings results. So companies with strong earnings and forward guidance will likely get DII if the early festival season gives good signs on the consumption front, that could also be a positive trigger. Until then, expect the market to remain in a sideways, consolidative phase for some time.
Economic Times
22 minutes ago
- Economic Times
India bonds may continue to see selling pressure at start of week
Indian government bonds are likely to see persistent selling pressure in early deals on Monday, as sentiment remains cautious after the benchmark bond yield rose above a key level in the previous session. ADVERTISEMENT The yield on the benchmark 10-year bond is likely to move between 6.33% and 6.37%, a trader at a private bank said, after closing at 6.3505% on Friday - the highest level since May 9. "Traders are losing interest and not building fresh positions, and hence we witnessed a large selloff after the debt auction on Friday," the trader said. The Reserve Bank of India sold 300 billion rupees ($3.47 billion) of the benchmark 2035 bond on Friday, the cutoff for which was in line with estimates, but the note witnessed selling pressure after the result was announced. Selling was exacerbated after the RBI governor's comments curbed expectations for rate easing, prompting those who were betting on an August cut to pare positions. ADVERTISEMENT Sanjay Malhotra said monetary policy, being forward-looking, will place greater focus on the outlook for growth and inflation, rather than their current levels, when the policy panel meets on August 6. Malhotra added that the bar for further easing is higher than it would have been if the stance was accommodative, though the RBI still has the flexibility to move the rates up, down or pause. ADVERTISEMENT A plunge in India's retail inflation to a more than six-year low and expectations that it will slip to a record low in July have led to increased talk of a rate cut in August. ADVERTISEMENT India's overnight index swap rates rose on Friday, as market participants trimmed rate cut bets for next week. The one-year OIS rate ended at 5.53% on Friday and the two-year OIS rate ended at 5.51%. The liquid five-year OIS rate settled at 5.73%. KEY INDICATORS: ** Benchmark Brent crude futures were 0.4% higher at $68.70 per barrel after easing 1.1% in the previous session ** Ten-year U.S. Treasury yield at 4.3938%; two-year yield at 3.9296% ($1 = 86.4750 Indian rupees). (You can now subscribe to our ETMarkets WhatsApp channel)
